Update on Diabetic Disease
Upfront: Monthly reflection by Editor in Chief Diana V. Do, MD.
-
By
-
Diana V. Do, MD
-
May 1, 2026
-
Clinical Scorecard: Update on Diabetic Disease
At a Glance
| Category | Detail |
|---|
| Condition | Diabetic Retinopathy (DR) and Diabetic Macular Edema (DME) |
| Key Mechanisms | Vision-threatening complications due to diabetes affecting retinal health. |
| Target Population | Patients with diabetes, particularly those exhibiting signs of diabetic retinopathy. |
| Care Setting | Ophthalmology clinics, particularly those specializing in retinal diseases. |
Key Highlights
- 30% of evaluated patients had diabetic retinopathy.
- Latest anti-VEGF treatments include faricimab and aflibercept 8 mg.
- Artificial intelligence is being utilized for DR screening.
- Importance of accurate ICD-10 coding for diabetic eye disease.
- Clinical trials are ongoing for innovative treatments like the PRIMA implant.
Guideline-Based Recommendations
Diagnosis
- Utilize retina imaging biomarkers for treatment selection in DME.
- Implement AI for screening to enhance detection rates.
Management
- Consider anti-VEGF therapies for managing DR and DME.
- Incorporate corticosteroids based on patient selection and dosing strategies.
Monitoring & Follow-up
- Regular follow-up for patients with diabetic retinopathy to assess progression.
- Monitor treatment response using imaging techniques.
Risks
- Potential complications from new treatments like the PRIMA implant.
- Risks associated with corticosteroid use in DME management.
Patient & Prescribing Data
Diabetic patients at risk for vision loss due to DR and DME.
Focus on personalized treatment plans based on individual patient needs and response.
Clinical Best Practices
- Ensure accurate documentation for ICD-10 coding to reflect care complexity.
- Stay updated on clinical trials for emerging therapies.
Related Resources & Content
